Benjamin Stone - 02 Aug 2026 Form 4 Insider Report for First Tracks Biotherapeutics, Inc. (TRAX)

Reporting relationship: Chief Business Officer
Issuer ticker: TRAX
Reported as of: 02 Aug 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Aug 2026, 18:26:27 UTC
Prior SEC filing: 14 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Ajim Tamboli, Attorney-in-Fact

Key filing fact

Benjamin Stone filed Form 4 for First Tracks Biotherapeutics, Inc. (TRAX) on 05 Aug 2026.

Key facts

This page summarizes Benjamin Stone's Form 4 filing for First Tracks Biotherapeutics, Inc. (TRAX).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Aug 2026, 18:26.

Change

Previous filing in this sequence was filed on 14 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002128786 Primary reporting owner

STONE BENJAMIN

Relationship: Chief Business Officer
Address: 10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO
Signature: /s/ Ajim Tamboli, Attorney-in-Fact
Signature date: 05 Aug 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TRAX transaction Derivative

Performance Stock Units

Award

Transaction value
Shares: +60,492
Change %: +363%
Price: $0.000000^*
Shares after: 77,159
Date: 02 Aug 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 60,492
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents performance-based restricted stock units ("PSUs") that were earned by the Reporting Person upon the achievement of certain performance criteria as certified by the Compensation Committee of the Issuer's Board of Directors on August 2, 2026.

Footnote F2

Each PSU represents a conditional right to receive one share of the Issuer's Common Stock.

Footnote F3

The PSUs vest and settle over two years; 50% vests on August 2, 2027 and 50% vests on July 1, 2028, subject to the continuing service of the Reporting Person on each vesting date.